Iq-ai Share Discussion Threads

[hazl] 30/11/2018 08:17

whenever I see that something is going to save firms money I sit up and listen.....


'This could result in substantial savings in healthcare systems globally and avoid all of the emerging toxicity concerns associated with contrast agents. This invention is based on Deep Learning (DL) techniques using only non-contrast MR images as inputs.'

shares magazine

[hazl] 29/11/2018 15:43

lastly an interesting blog...

[hazl] 29/11/2018 15:33

This lady is apparently the second largest shareholder and would know what she is talking about I would guess!
I haven't checked this out but according to a L S E poster

[hazl] 29/11/2018 13:37

Non-toxic MRIs

'The group is also working to tackle the relatively new issue of gadolinium toxicity, having filed a patent in October for gadolinium-free magnetic resonance imaging (MRI).

Gadolinium is the name for a group of chemical substances used in MRI scans, however research over the last decade has revealed that the compounds can potentially cause nephrogenic systemic fibrosis (NSF) in a small number of patients, particularly those with compromised kidney functions.'

[hazl] 29/11/2018 13:37

Sorry to flood the board but just putting up my info as I find it.

[hazl] 29/11/2018 13:33

StoneChecker : A Novel Standardized Quantitative Imaging Software in Urolithiasis
All Day | QRR016 | QIRR, Learning Center
PARTICIPANTS:
Balaji Ganeshan, PhD london, united kingdom (Presenter)
Disclosure: CEO, Feedback plc Director, Feedback plc Director, Stone Checker Software Ltd Director, Prostate Checker Ltd
Helen W. Cui, MRCS oxford, united kingdom
Disclosure: Research Grant, McLaren Applied Technologies Travel support, Stonechecker Software Ltd Spouse, Employee, Blue Earth Diagnostics Ltd Spouse, Former Consultant, Stonechecker Software Ltd
Daniel J. Stevens wallingford, united kingdom
Disclosure: Medical Director, Blue Earth Diagnostics Ltd Advisor, StoneChecker
Sugam Taneja, MD,MBA radstock, united kingdom
Disclosure: Employee, StoneChecker Software
CITE THIS ABSTRACT
BACKGROUND
It is estimated that 30-35% of all lithotripsy (ESWL) procedures fail to deliver effective treatment.1More recently, the efficacy of ureteroscopic stone clearance has been shown to be lower than previously thought.2Understanding the composition and architecture of kidney stones is crucially important for optimal treatment selection, allowing the improvement of treatment outcomes and overall patient experience in a cost-effective manner.3A recent article highlights the use of CT Texture Analysis (CTTA) technique to analyse renal stones and to predict ease of fragmentation with lithotripsy in detail.4 AIM: To demonstrate a semi-automated imaging workflow tool - StoneChecker (SC) as a part of routine kidney stone assessment on a non-contrast Kidneys-Ureters-Bladder(KUB) CT scan.
METHODOLOGY/APPLICATION
Describe and evaluate an automated kidney stone assessment, ROI identification and analysis approach. Report kidney stone heterogeneity and other kidney stone metrics (axial length, volume, density, Skin to stone distance-SSD, area of stone cross-section,'

Thanks ged5 very useful.
Chicago this week and very informative by the looks of it..
A market waiting to be utilised,it appears.

[hazl] 29/11/2018 11:49

Thanks ged5 Hi Volsung

[ged5] 29/11/2018 11:41

From my research in FDBK I came across this a couple of weeks ago after the Stonechecker announcement.

Balaji Ganeshan has been presenting this week at RSNA in Chicago about Stonechecker. It seems Texrad is used in several applications.

[volsung] 29/11/2018 11:02

Added to the watchlist hazl

[hazl] 29/11/2018 10:46

It seems the country has an estimated 300,000 new cases of kidney stone disease each year, despite a population of only 51mln, South Korea is a key market for IQ-AI.

StoneChecker has already received European CE clearance, while approval from US regulators is expected soon.

I like the fact the detector for the tumours uses a better Gadolinium free method.

IMO
.

[hazl] 29/11/2018 09:43

Imaging Biometrics develops a number of ready-to-use software applications for the healthcare industry focused around medical imaging for conditions such as brain tumours.

The company has also recently received ISO 13485:2016 certification for its products, an internationally recognised quality standard supporting the design, development, manufacture, and distribution of medical devices that is a regulatory requirement for the industry.

[hazl] 29/11/2018 09:41

Also Smith says he is expecting the product market access to the USA.

[hazl] 29/11/2018 09:25

They are already getting sales.
From the RNS from the 16th of November.


'Q-AI is pleased to announce the first commercial sale of its StoneChecker Software.

The Company's South Korean distributor has received its first order for the product from a prominent South Korean hospital.

David Smith, Chief Operating Officer of IQ-AI commented, "We are delighted to announce this significant commercial milestone for StoneChecker Software. The enthusiasm and commercial interest with which the product has been greeted upon its introduction to South Korea bodes well for the global market. We look forward to making further announcements as we expand distribution."

[hazl] 29/11/2018 08:54

Have noticed these and decided to get a few.

[mertymcs] 27/11/2018 18:37

Was the 90 day FDA approval period business days or standard days?

[colin12345678] 23/11/2018 09:01

Looking like news inbound it is due end of the month

[leonsito] 18/11/2018 19:43

Chart analysis courtesy of rosolanor on Twitter https://twitter.com/rosolanor/status/1064233154557460480

[amrishbhim] 16/11/2018 08:35

This is the future , South Korea technology nothing but the best. Let's see where the company takes us over the coming months and years

[andrbea] 16/11/2018 08:29

milestone rns

David Smith, Chief Operating Officer of IQ-AI commented, "We are delighted to announce this significant commercial milestone for StoneChecker Software. The enthusiasm and commercial interest with which the product has been greeted upon its introduction to South Korea bodes well for the global market. We look forward to making further announcements as we expand distribution."

[burtond1] 16/10/2018 10:46

https://total-market-solutions.com/2018/10/16/iq-ai/TMS article worth a read up...

[ferris_bueller] 09/10/2018 07:57

Formerly Flying Brand (FBDU)

Trevor Brown CEO, commented "The new name, IQ-AI is the acronym for Imaging Quantification- Artificial Intelligence, which powerfully acknowledges the strategic focus of our group businesses in coming years. "